{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:11:37Z","timestamp":1793502697350,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The University of Osaka","id":[{"id":"https:\/\/ror.org\/035t8zc32","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gen Thorac Cardiovasc Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the surgical outcomes of surgical aortic valve replacement in the transcatheter aortic valve replacement era and propose a novel patient-specific prognostic model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We randomly divided 772 patients with aortic stenosis who underwent surgical aortic valve replacement in 2016\u20132021 into two cohorts (derivation, 515; validation, 257). In the derivation cohort, no data were missing for any patients for the candidate predictors including age, sex, body mass index, left ventricular ejection fraction, levels of albumin, hemoglobin, and serum creatinine, presence of chronic atrial fibrillation, and end-stage renal disease requiring hemodialysis. We developed possible scoring models using Cox proportional hazards regression with overall survival as the endpoint and calculated the cross-validated 5-year C-statistics to assess accuracy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean patient age was 74.2\u00a0years, and 46.9% were female. Kaplan\u2013Meier analysis revealed overall 1- and 5-year survival rates of 96.6 and 88.7%, respectively. The 5-year C-statistic of the derivation cohort was 0.785 (95% confidence interval: 0.716\u20130.853), while the estimated 1-, 3-, and 5-year C-statistics of the validation cohort were 0.885 (0.806\u20130.965), 0.888 (0.824\u20130.953), and 0.801 (0.702\u20130.901), respectively. Calibration plots revealed good agreement between predicted and actual 5-year survival (intraclass correlation coefficient\u2009=\u20090.955; 95% confidence interval: 0.827\u20130.989).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This novel survival prediction model after isolated surgical aortic valve replacement in the transcatheter aortic valve replacement era showed good survival prediction, and may guide the decision-making process for surgical aortic valve replacement versus transcatheter aortic valve replacement with lifetime management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11748-026-02326-3","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T18:18:04Z","timestamp":1781288284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A novel survival prediction model after isolated surgical aortic valve replacement in the transcatheter aortic valve replacement era"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1102-111X","authenticated-orcid":false,"given":"Koichi","family":"Maeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyongsun","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Yanagino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Misumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"2326_CR1","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","volume":"380","author":"MJ Mack","year":"2019","unstructured":"Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695\u2013705. https:\/\/doi.org\/10.1056\/NEJMoa1814052.","journal-title":"N Engl J Med"},{"key":"2326_CR2","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","volume":"380","author":"JJ Popma","year":"2019","unstructured":"Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O\u2019Hair D, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706\u201315. https:\/\/doi.org\/10.1056\/NEJMoa1816885.","journal-title":"N Engl J Med"},{"key":"2326_CR3","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1093\/eurheartj\/ehae043","volume":"45","author":"HGH Thyregod","year":"2024","unstructured":"Thyregod HGH, J\u00f8rgensen TH, Ihlemann N, Steinbr\u00fcchel DA, Nissen H, Kjeldsen BJ, et al. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial. Eur Heart J. 2024;45:1116\u201324. https:\/\/doi.org\/10.1093\/eurheartj\/ehae043.","journal-title":"Eur Heart J"},{"key":"2326_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5761\/atcs.oa.24-00123","volume":"30","author":"K Handa","year":"2024","unstructured":"Handa K, Maeda K, Pak K, Shimamura K, Yamashita K, Kawamura A, et al. Midterm clinical outcomes after isolated surgical and transcatheter aortic valve replacement in low-risk patients with aortic stenosis. Ann Thorac Cardiovasc Surg. 2024;30:24\u201300123. https:\/\/doi.org\/10.5761\/atcs.oa.24-00123.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"2326_CR5","doi-asserted-by":"publisher","first-page":"ezag022","DOI":"10.1093\/ejcts\/ezag022","volume":"68","author":"K Handa","year":"2026","unstructured":"Handa K, Maeda K, Pak K, Yanagino Y, Ohmori T, Ohtani A, et al. Left atrial volume index as a risk predictor in isolated surgical aortic valve replacement: Results from the multicentre aortic valve replacement registry. Eur J Cardiothorac Surg. 2026;68:ezag022. https:\/\/doi.org\/10.1093\/ejcts\/ezag022.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2326_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jjcc.2023.05.012","volume":"82","author":"K Maeda","year":"2023","unstructured":"Maeda K, Shimamura K, Yoshioka D, Inoue K, Yamada S, Yamashita K, et al. Midterm outcomes after surgical aortic valve replacement with the INSPIRIS RESILIA from a multicenter AVR registry. J Cardiol. 2023;82:261\u20137. https:\/\/doi.org\/10.1016\/j.jjcc.2023.05.012.","journal-title":"J Cardiol"},{"key":"2326_CR7","doi-asserted-by":"publisher","first-page":"ezaf437","DOI":"10.1093\/ejcts\/ezaf437","volume":"68","author":"T Taguchi","year":"2026","unstructured":"Taguchi T, Maeda K, Yanagino Y, Ohmori T, Ohtani A, Kumagai K, et al. Effect of mitral annular calcification on outcomes following transcatheter aortic valve replacement. Eur J Cardiothorac Surg. 2026;68:ezaf437. https:\/\/doi.org\/10.1093\/ejcts\/ezaf437.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2326_CR8","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/sim.4154","volume":"30","author":"H Uno","year":"2011","unstructured":"Uno H, Cai T, Pencina MJ, D\u2019Agostino RB, Wei LJ. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med. 2011;30:1105\u201317. https:\/\/doi.org\/10.1002\/sim.4154.","journal-title":"Stat Med"},{"key":"2326_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361\u201387. https:\/\/doi.org\/10.1002\/(SICI)1097-0258(19960229)15:4%3C361::AID-SIM168%3E3.0.CO.","journal-title":"Stat Med"},{"key":"2326_CR10","volume-title":"Applied survival analysis: Regression modeling of time to event data","author":"DW Hosmer","year":"1999","unstructured":"Hosmer DW, Lemeshow S. Applied survival analysis: Regression modeling of time to event data. New York: John Wiley & Sons, Inc.; 1999."},{"key":"2326_CR11","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","volume":"363","author":"MB Leon","year":"2010","unstructured":"Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597\u2013607. https:\/\/doi.org\/10.1056\/NEJMoa1008232.","journal-title":"N Engl J Med"},{"key":"2326_CR12","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","volume":"364","author":"CR Smith","year":"2011","unstructured":"Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187\u201398. https:\/\/doi.org\/10.1056\/NEJMoa1103510.","journal-title":"N Engl J Med"},{"key":"2326_CR13","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","volume":"374","author":"MB Leon","year":"2016","unstructured":"Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1514616.","journal-title":"N Engl J Med"},{"key":"2326_CR14","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/ejcts\/ezs043","volume":"41","author":"SAM Nashef","year":"2012","unstructured":"Nashef SAM, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734\u201344. https:\/\/doi.org\/10.1093\/ejcts\/ezs043. discussion 44\u20135.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2326_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11748-020-01436-w","volume":"69","author":"K Maeda","year":"2021","unstructured":"Maeda K, Kuratani T, Pak K, Shimamura K, Mizote I, Miyagawa S, et al. Development of a new risk model for a prognostic prediction after transcatheter aortic valve replacement. Gen Thorac Cardiovasc Surg. 2021;69:44\u201350. https:\/\/doi.org\/10.1007\/s11748-020-01436-w.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2326_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ahj.2016.08.016","volume":"182","author":"V Dahya","year":"2016","unstructured":"Dahya V, Xiao J, Prado CM, Burroughs P, McGee D, Silva AC, et al. Computed tomography-derived skeletal muscle index: A novel predictor of frailty and hospital length of stay after transcatheter aortic valve replacement. Am Heart J. 2016;182:21\u20137. https:\/\/doi.org\/10.1016\/j.ahj.2016.08.016.","journal-title":"Am Heart J"},{"key":"2326_CR17","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jtcvs.2015.11.022","volume":"151","author":"R Paknikar","year":"2016","unstructured":"Paknikar R, Friedman J, Cron D, Deeb GM, Chetcuti S, Grossman PM, et al. Psoas muscle size as a frailty measure for open and transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2016;151:745\u201351. https:\/\/doi.org\/10.1016\/j.jtcvs.2015.11.022.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2326_CR18","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1056\/NEJMoa1200384","volume":"366","author":"SK Kodali","year":"2012","unstructured":"Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686\u201395. https:\/\/doi.org\/10.1056\/NEJMoa1200384.","journal-title":"N Engl J Med"},{"key":"2326_CR19","doi-asserted-by":"publisher","first-page":"e005048","DOI":"10.1161\/CIRCOUTCOMES.118.005048","volume":"11","author":"H Kundi","year":"2018","unstructured":"Kundi H, Valsdottir LR, Popma JJ, Cohen DJ, Strom JB, Pinto DS, et al. Impact of a claims-based frailty indicator on the prediction of long-term mortality after transcatheter aortic valve replacement in medicare beneficiaries. Circ Cardiovasc Qual Outcomes. 2018;11:e005048. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.118.005048.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2326_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jcin.2017.11.012","volume":"11","author":"AW Schoenenberger","year":"2018","unstructured":"Schoenenberger AW, Moser A, Bertschi D, Wenaweser P, Windecker S, Carrel T, et al. Improvement of risk prediction after transcatheter aortic valve replacement by combining frailty with conventional risk scores. JACC Cardiovasc Interv. 2018;11:395\u2013403. https:\/\/doi.org\/10.1016\/j.jcin.2017.11.012.","journal-title":"JACC Cardiovasc Interv"},{"key":"2326_CR21","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.amjcard.2016.05.052","volume":"118","author":"Y Watanabe","year":"2016","unstructured":"Watanabe Y, Kozuma K, Hioki H, Kawashima H, Nara Y, Kataoka A, et al. Comparison of results of transcatheter aortic valve implantation in patients with versus without active cancer. Am J Cardiol. 2016;118:572\u20137. https:\/\/doi.org\/10.1016\/j.amjcard.2016.05.052.","journal-title":"Am J Cardiol"},{"key":"2326_CR22","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.athoracsur.2021.12.058","volume":"115","author":"JE Bavaria","year":"2022","unstructured":"Bavaria JE, Griffith B, Heimansohn DA, Rozanski J, Johnston DR, Bartus K, et al. Five-year outcomes of the COMMENCE trial investigating aortic valve replacement with RESILIA tissue. Ann Thorac Surg. 2022;115:1429\u201336. https:\/\/doi.org\/10.1016\/j.athoracsur.2021.12.058.","journal-title":"Ann Thorac Surg"},{"key":"2326_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.athoracsur.2018.01.090","volume":"106","author":"JM Fallon","year":"2018","unstructured":"Fallon JM, DeSimone JP, Brennan JM, O\u2019Brien S, Thibault DP, DiScipio AW, et al. The incidence and consequence of prosthesis-patient mismatch after surgical aortic valve replacement. Ann Thorac Surg. 2018;106:14\u201322. https:\/\/doi.org\/10.1016\/j.athoracsur.2018.01.090.","journal-title":"Ann Thorac Surg"},{"key":"2326_CR24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/ejcts\/ezab140","volume":"60","author":"D Hernandez-Vaquero","year":"2021","unstructured":"Hernandez-Vaquero D, Rodriguez-Caulo E, Vigil-Escalera C, Blanco-Herrera O, Berastegui E, Arias-Dachary J, et al. Differences in life expectancy between men and women after aortic valve replacement. Eur J Cardiothorac Surg. 2021;60:681\u20138. https:\/\/doi.org\/10.1093\/ejcts\/ezab140.","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["General Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-026-02326-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11748-026-02326-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-026-02326-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:03:28Z","timestamp":1793329408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11748-026-02326-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":24,"alternative-id":["2326"],"URL":"https:\/\/doi.org\/10.1007\/s11748-026-02326-3","relation":{},"ISSN":["1863-6705","1863-6713"],"issn-type":[{"value":"1863-6705","type":"print"},{"value":"1863-6713","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KM and KS are TAVR proctors for the SAPIEN and Evolut series; KM, TO, and KH received\u00a0research grants from Edwards Lifesciences; and\u00a0KM has received research grants from Medtronic. The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the University of Osaka (approval number: 20222 (T2)).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}